Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank86
3Y CAGR+96.8%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+96.8%/yr
Annual compound
Percentile
P86
Within normal range
vs 3Y Ago
7.6x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 30.33% |
| 2023 | -673.67% |
| 2022 | 139.42% |
| 2021 | 3.98% |
| 2020 | -1.60% |
| 2019 | -4.15% |
| 2018 | 4.22% |
| 2017 | -3.50% |
| 2016 | -12.14% |
| 2015 | -28.21% |